Continued Demand Due to Centers for Medicare
& Medicaid Services Policy
Strongest Sales Channel in Company
History
Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the
“Company”), a pathogen elimination technology company that applies
the power of narrow-range ultraviolet light (“UVC”) for surface
areas and catalytic bioconversion technology for air purification
to destroy pathogens safely, thoroughly, and automatically,
announces MedLine, its exclusive North American Scientific Air
Management healthcare distribution partner, has placed a large
multi-unit follow-on order for its patented S200 mobile air
purification system.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220705005112/en/
Scientific Air S400 (Photo: Business
Wire)
Since 2015 Scientific Air patented three-stage, advanced UVC
Carbon and HEPA filtration systems have been improving indoor air
quality 24/7 in high-traffic, occupied spaces at leading healthcare
facilities throughout the USA, including Athena Healthcare
Systems, Advent Healthcare, NYU Medical Center, University
of Rochester Medical Center, The Federal VA Hospital System,
Baptist Health South Miami, Kaiser Permanente
Medical of California, and New York Health + Hospital
Corp.
Newest COVID variant spreading rapidly throughout the US
The follow-on order for our mobile S200 air purification is in
further support of the Centers for Medicare and Medicaid Services
(CMS) Policy announced earlier in the year to ease visitation in
Long-term Care facilities. Under the CMS policy guidance, it
provides funding available for long-term care providers looking to
make air quality upgrades to their facilities to reduce the spread
of COVID-19.
Additionally, the air purification sales channel is the
strongest in the Company’s history due in part to, increased
awareness around improving indoor air quality, the impact of the
marketing campaign launched earlier in the quarter, coupled with
our expanded domestic distribution reach. Collectively, these
combined efforts are positively impacting the Company’s air
purification sales channel pipeline across multiple verticals. If
the Company is successful in converting the pipeline that includes
several multi-million-dollar contract bids, to closed sales, this
could impact revenue significantly over the next 6-12 months.
“The CMS Policy guidance acknowledges the critical role that
pathogen elimination solutions can play in protecting both the
frontline Heroes in Long-term Care and the elderly patients in
their care in the fight against the spread of COVID-19 and other
airborne pathogens,” stated John F. Andrews, Applied UV’s CEO and
Director. “This initiative CMS has unleashed, ensures that cost is
not a barrier for long-term care providers wishing to ease
visitation restrictions that have been in place, but also offers
longer term solutions to protect its patients, staff, and visitors.
It has been well documented the unimaginable emotional toll placed
on families who have been physically separated by strict facility
visitation restrictions throughout the course of this 3-year
pandemic.”
Mr. Andrews continued, “Healthcare is a key vertical market for
us. We work with hundreds of leaders in healthcare facilities
across the country where pathogen spread is an ever-present
challenge. Our patented air purification technology has been
independently tested and scientifically proven to eliminate
airborne pathogens including SARS COV-2 (Covid-19). Our Scientific
Air Management S-200 is a mobile, easy to use solution to mitigate
against the spread of respiratory infections in long-term care
facilities creating a cleaner and safer environment for visitation.
We look forward to working closely with MedLine who is one of the
largest distributors in healthcare as we expand our market share
and presence in LTC. With our expanding sales pipeline, our entire
team is focused on closing contracts, increasing market share, and
executing on our business plan.”
Scientific Air Product Portfolio
Developed for healthcare facilities, Scientific Air is helping
large facilities and hospitals across the country address the
growing need for effective and safe airborne Infection prevention.
Scientific Air-S200 Operating Overview:
- Laboratory validated 99.99%+ kill rate on viruses, bacteria,
mold, odors and VOCS
- No harmful by-products
- Rapid, portable, whole-room disinfection via patented 3-phase
design (HEPA, UV-C, Carbon)
- Safe and fast acting in occupied spaces
- Proven and tested in facilities with EPA and FDA guideline
compliance and trusted by Infection Prevention, Facilities, EHS and
EVS professionals
Follow us on Twitter Follow us on LinkedIn
About Applied UV
Applied UV is focused on the development and acquisition of
technology that address infection control in the healthcare,
hospitality, commercial and municipal markets. The Company has two
wholly owned subsidiaries - SteriLumen, Inc. (“SteriLumen”) and
Munn Works, LLC (“Munn Works”). SteriLumen’s connected platform for
Data Driven Disinfection™ applies the power of ultraviolet light
(UVC) to destroy pathogens safely, thoroughly, and automatically,
addressing the challenge of healthcare-acquired infections
("HAIs"). Targeted for use in facilities that have high customer
turnover such as hospitals, hotels, commercial facilities, and
other public spaces, the Company’s Lumicide™ platform uses UVC LEDs
in several patented designs for infection control in and around
high-traffic areas, including sinks and restrooms, killing
bacteria, viruses, and other pathogens residing on hard surfaces
within devices’ proximity. The Company’s patented in-drain
disinfection device, Lumicide Drain, is the only product on the
market that addresses this critical pathogen intensive location.
SteriLumen’s Airocide® air purification devices are research
backed, clinically proven and developed for NASA with assistance
from the University of Wisconsin. Airocide® is listed as an FDA
Class II Medical device, utilizes a proprietary photocatalytic
(PCO) bioconversion technology that draws air into a reaction
chamber that converts damaging molds, microorganisms, dangerous
airborne pathogens, destructive VOCs, allergens, odors and
biological gasses into harmless water vapor and green carbon
dioxide without producing ozone or other harmful byproducts.
Airocide® applications include healthcare, hospitality, grocery
chains, wine making facilities, commercial real estate, schools,
dental offices, post-harvest, grocery, cannabis facilities and
homes. For more information about Applied UV, Inc., and its
subsidiaries, please visit the following websites:
https://www.applieduvinc.com/
Forward-Looking Statements
The information contained herein may contain “forward‐looking
statements.” Forward‐looking statements reflect the current view
about future events. When used in this press release, the words
“anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,”
“plan,” or the negative of these terms and similar expressions, as
they relate to us or our management, identify forward‐looking
statements. Such statements include, but are not limited to,
statements contained in this press release relating to the view of
management of Applied UV concerning its business strategy, future
operating results and liquidity and capital resources outlook.
Forward‐looking statements are based on the Company’s current
expectations and assumptions regarding its business, the economy
and other future conditions. Because forward–looking statements
relate to the future, they are subject to inherent uncertainties,
risks and changes in circumstances that are difficult to predict.
The Company’s actual results may differ materially from those
contemplated by the forward‐looking statements. They are neither
statements of historical fact nor guarantees of assurance of future
performance. We caution you therefore against relying on any of
these forward‐looking statements. Factors or events that could
cause the Company’s actual results to differ may emerge from time
to time, and it is not possible for the Company to predict all of
them. The Company cannot guarantee future results, levels of
activity, performance, or achievements. Except as required by
applicable law, including the securities laws of the United States,
the Company does not intend to update any of the forward‐looking
statements to conform these statements to actual results.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220705005112/en/
Applied UV Inc. John F. Andrews Applied UV CEO, Director
john.andrews@applieduvinc.com
Brett Maas, Managing Principal Hayden IR brett@haydenir.com
(646) 536-7331
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Sep 2023 to Sep 2024